The Hospitalist

HIV Treatment Has Come a Long Way, Although Complications, Comorbidities Remain

HIV treatment has significantly evolved over the past 30 years, transforming HIV from a fatal disease to a manageable chronic ...
Healio

Q&A: Transplant nephrologist on finding her ‘niche’ in nephrology

For Michelle A. Josephson, MD, FASN, the field of transplant nephrology provided opportunities to make a difference as a ...
C&EN

Nov. 25 Business Watch: Flexsys readies safer tire additive; Moderna halts trials of 3 mRNA drugs

C&EN networking event in New York City. Please join us if you’re in town! Here’s a link to the invitation. Questions? Comments? Tips? Let us know. Email Michael McCoy, C&EN’s executive editor for ...
PCGamesN

Once Human codes and how to redeem

November 27, 2025: We checked for new Once Human codes. Our current list provides a healthy injection of Starchrom, used at the Wish Machine, Paradise Coins for the Paradise Store, and other handy ...
Le Lézard

Bristol Myers Squibb Data at ASH 2025 Showcase Potential of Hematology Pipeline and Build Momentum for Next Generation Portfolio

Bristol Myers Squibb today announced the presentation of more than 95 data disclosures, including 27 oral presentations, across company-sponsored studies and external collaborations at the 67th ...

IMFINZI® approved in the US as first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers

AstraZeneca’s IMFINZI® (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) has been approved in the US for the treatment of adult ...